| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC11450 | Selpercatinib(LOXO-292) Featured | Selpercatinib is a RET kinase inhibitor extracted from patent WO2018071447A1, Compound Example 163, has an IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M) , and RET (G810R), respectively. Antineoplastic activity. |
|
